Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: BioNTech SE

Market Cap 20.03B 22.96B 18.54B 17.38B 32.54B 2,166B 32.77B 220B 85.2B 1,067B 86.16B 84.3B 3,707B P/E 2026 *
-18x
P/E 2027 * -17.7x
Enterprise Value 9.17B 10.52B 8.49B 7.96B 14.9B 992B 15.01B 101B 39.03B 489B 39.47B 38.62B 1,698B EV / Sales 2026 *
4.24x
EV / Sales 2027 * 4.82x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day-1.44%
1 week+0.39%
Current month-5.27%
1 month+0.59%
3 months+1.81%
6 months-1.74%
Current year-4.53%
1 week 89.34
Extreme 89.34
93.25
1 month 84.96
Extreme 84.955
97.44
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
05-12Free

Executive/Senior Manager

22,655 0.0094%
05-12Free

Chief Operating Officer

22,655 0.0094%
05-12Free

Chief Financial Officer

33,982 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%+0.39%-14.68%-17.33% 22.98B
+1.44%-1.25%+64.25%+114.23% 55.19B
+4.60%+3.02%+57.38%+48.98% 45.75B
-2.69%-2.10%-6.70%+374.02% 20.76B
+3.22%-0.84%+27.88%-20.46% 16.26B
+0.58%+1.08%+18.85%-37.32% 15.42B
-1.01%-2.30%+28.59%+174.08% 13.05B
+4.95%+11.70%+125.78%+252.19% 12.45B
+3.07%+0.14%+29.05% - 12.37B
+1.18%+5.20%+77.00%+106.03% 11.66B
Average +1.39%+2.67%+40.74%+110.49% 22.59B
Weighted average by Cap. +1.60%+1.74%+42.65%+101.40%

Financials

2026 *2027 *
Net sales 2.17B 2.48B 2.01B 1.88B 3.52B 234B 3.54B 23.8B 9.21B 115B 9.32B 9.12B 401B 2.23B 2.56B 2.06B 1.94B 3.62B 241B 3.65B 24.51B 9.49B 119B 9.6B 9.39B 413B
Net income -1.05B -1.2B -973M -912M -1.71B -114B -1.72B -11.55B -4.47B -55.99B -4.52B -4.42B -194B -1.17B -1.34B -1.08B -1.01B -1.89B -126B -1.91B -12.81B -4.96B -62.09B -5.01B -4.91B -216B
Net Debt -10.85B -12.44B -10.05B -9.42B -17.63B -1,174B -17.76B -119B -46.17B -578B -46.69B -45.68B -2,009B -9.28B -10.64B -8.59B -8.05B -15.08B -1,004B -15.19B -102B -39.49B -494B -39.93B -39.06B -1,718B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
18/06/26 90.89 $ -1.44% 939,598
17/06/26 92.22 $ +3.04% 902,500
16/06/26 89.50 $ -1.43% 819,247
15/06/26 90.80 $ +0.29% 825,403
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
79.19EUR
Average target price
106.75EUR
Spread / Average Target
+34.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!